DAEWOONG CO.,LTD Logo

DAEWOONG CO.,LTD

003090 | KO

Overview

Corporate Details

ISIN(s):
KR7003090008
LEI:
Country:
South Korea
Address:
경기 성남시 중원구 상대원동 223-23, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 14.9 KB
2025-09-05 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 9.0 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 3.7 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 4.0 MB
2025-07-30 00:00
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 9.5 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 708.5 KB
2025-05-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.7 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 162.0 KB
2025-05-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 58.0 KB
2025-05-15 00:00
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
Korean 54.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-05-14 00:00
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
Korean 60.7 KB
2025-04-16 00:00
Capital/Financing Update
단기차입금증가결정(자회사의 주요경영사항)
Korean 11.5 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-04-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 62.4 KB

Automate Your Workflow. Get a real-time feed of all DAEWOONG CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DAEWOONG CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DAEWOONG CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America
SPRY

Talk to a Data Expert

Have a question? We'll get back to you promptly.